讲者介绍
Dr. Thomas Polasek [BSc, BPharm (Hons), MD, PhD (Clinical Pharmacology), FCP] is the Deputy Medical Director and a Principal Investigator at CMAX Clinical Research. Tom holds advanced qualifications in Clinical Pharmacology, Medicine, and Pharmacy, bringing a unique multidisciplinary approach to our clinical trials and participants.
Dr. Polasek has been an Investigator in over 100 clinical studies and has produced more than 150 peer-reviewed publications and conference presentations influencing drug development strategies and clinical practices worldwide. This work has supported innovations across multiple, diverse therapeutic areas including infectious diseases, oncology, endocrinology and neurodegenerative disorders.
Dr. Polasek serves as Adjunct Senior Lecturer at Monash University and has worked as the Director of Clinical Pharmacology for Certara USA. Tom is a Fellow of the American College of Clinical Pharmacology and has an accomplished career as a researcher, having a particular interest in clinical pharmacology focussed on variability in drug response and novel therapies.
Dr Polasek also enjoys working on later phase patient studies at CMAX’s sister company, Fusion Clinical Research.
A/Prof Rohit Joshi is a Medical Oncology Consultant working at the Lyell McEwin, Calvary Connery & St Andrew’s Hospitals. He is an Associate Professor at the University of South Australia and University of Adelaide.
He completed his undergraduate and postgraduate training at the Christian Medical College in India, after which he trained in Medical Oncology at the Royal Adelaide Hospital. His main research interests include clinical trials and new drugs therapies in breast, lung, colorectal, and other solid tumours, along with supportive and palliative care studies.
Rohit treats solid cancers with major interests in breast, lung, gastro-intestinal and kidney cancers.
Dr Ganessan Kichenadasse is an Oncologist and a Pharmacologist with special interest in the management of variety of cancers such as brain, gynaecological, genitourinary (bladder, kidney, prostate), sarcomas, breast, thyroid cancers, cancer of unknown primary and other rare cancers.
His other passion is conduct and design of all phases of clinical trials for cancer therapies with a focus on early phase (first in human) drug trials. He is an active member of several national and international cancer and pharmacology professional associations.
He holds multiple leadership roles within South Australian Neurological Tumour Bank; state-wide clinical cancer network and SA health cancer drug committee. He is an active member of the management committee of COGNO, and a long-term research committee member for ANZGOG.
会议报名
免费参会
（报名需审核，审核通过后视为报名成功）
欢迎有意到澳大利亚开展临床试验的企业代表报名参加！
识别二维码或点击文末“阅读原文”报名参会
报名咨询：cheng.long@pharmadj.com
关于澳大利亚南澳州政府经济发展部
澳大利亚南澳州政府经济发展部（DSD）中国代表处致力于推动南澳州与中国两地的贸易与投资来往与合作，并在上海、济南、广州与香港设立有办公室。
关于研发客
研发客由行业资深记者和编辑于2014年创立，目前已经成为中国医药行业权威的多元化平台，包括全媒体资讯、研究院、行业峰会和传播咨询培训等。
我们的关注领域贯穿整个药物的生命周期，从科学转化、药物早期研究到临床开发、商业化定价，以及市场准入策略、公关传播策略等。
目前研发客全媒体资讯平台覆盖网站、微信公众号、雪球、今日头条、领英等中英文平台的官方号，在中国上海、广州、北京、苏州，以及美国新泽西、加拿大温哥华、日本东京、大阪等地常驻资深编辑和撰稿人，推出多个具有影响力的专栏。我们希望通过研究、调研和报道，成为中国医药行业的灯塔。